‘Innovations in Clinical Pharmacy Practice, Education and Research’ will be the topic of the forthcoming ESCP Symposium, to be held in Aberdeen, Scotland in Autumn 2023. In this… read more.
The Oath to Society, jointly developed by ESCP and EAHP underpins clinical pharmacy services and highlights pharmacists’ work to those outside the profession, according to ESCP President, Professor… read more.
ESCP recognises that the translation of academic evidence into day-to-day practice is an important step in the development of clinical pharmacy services – and ESCP Best Practice papers… read more.
ESCP is a dynamic organisation that responds to the needs of its members and in doing so it has undertaken a number of key developments in recent years,… read more.
‘Innovations in Clinical Pharmacy Practice, Education and Research’ will be the topic of the forthcoming ESCP Symposium, to be held in Aberdeen, Scotland in Autumn 2023. IMI spoke… read more.
Ivermectin is an effective antiviral agent with a long record of successful use in human and animal parasite infestations. Its value as part of the early treatment for… read more.
Pharmacogenomics and personalised medicine are increasingly becoming a part of mainstream healthcare and it is an area where pharmacists have a major part to play. In this series… read more.
Recent research has demonstrated the value of pharmacogenomics-guided prescribing but this is a far cry from the implementation of routine services. Dr Raliate Onatade Chief Pharmacist for North… read more.
A number of examples show how pharmacogenetic testing is being integrated into day-to-day practice and helping to improve the safe and effective use of medicines, Raliat Onatade, Chief… read more.
Raliat Onatade, Chief Pharmacist for North Thames Genomic Medicines Service Alliance, recently gave the opening keynote address at the EAHP Congress in Lisbon (March 2023) on the subject… read more.
On 27th June 2023 NHS England issued a Medicine Supply Notification (MSN/2023/061) concerning GLP-1 receptor agonists (GLP-1 RAs) used for management of type 2 diabetes. This action has… read more.
A recent publication described the holistic approach to drug therapy in a patient with heart failure – an area where treatment has changed considerably over the past 30… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
